/ Physicians


The issue: Erythromycin 250 mg oral tablets have been discontinued from the sole manufacturer in Canada.

August 2022 formulary update - effective August 11, 2022

Included in the update:

The Issue: dimercaprol 300 mg vials have been discontinued in Canada.

June 2022 formulary update - effective June 22, 2022

Northern Health (NH) will be receiving a team of seven Accreditation Canada Surveyors between July 10-15, 2022 to complete the second half of our evaluation on Primary and Community Care & Population Health.

Resolution: Moxifloxacin 400 mg injectable is now available in good supply and this drug shortage can be considered resolved.

Date: June 10, 2022